Please login to the form below

Not currently logged in
Email:
Password:

Boston Pharma appoints ex-Pfizer and Sanofi executives

Santiago Arroyo and Constantine Chinoporos join its senior team

Constantine ChinoporosBoston Pharmaceuticals has appointed Santiago Arroyo as chief medical officer and Constantine Chinoporos as chief business officer to further build and develop its portfolio.

The company is led by ex-Sanofi CEO Chris Viehbacher and one of Boston's new senior hires comes from the French pharma firm.

Chinoporos was previously vice president of global licensing and business development at Sanofi and has also served as vice president of corporate development at Genzyme and alliance manager or primary care product group at Lilly.

He said: “Boston Pharmaceuticals is intensely focused on efficient clinical development of new medicines and I look forward to helping build an extensive portfolio of new and novel products.

“This is an opportunity to leverage my extensive network of industry partners in identifying great licensing opportunities that can ultimately benefit patients.”

Santiago ArroyoMeanwhile, Arroyo (pictured left) arrives from Pfizer, where he was senior vice president and chief medical officer, having previously also held senior positions at Bristol-Myers Squibb and Eisai.

He said: “I am excited to be part of Boston Pharmaceuticals and to join the team creating a substantial portfolio of clinical programmes across important disease states to bring new medicine to patients.

“I look forward to partnering with biotechnology and biopharmaceutical companies in identifying and further developing potential new medicines.” 

27th November 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics